Understanding the financial challenges faced by patients with chronic obstructive pulmonary disease (COPD)
Official title: Financial Toxicity in Chronic Obstructive Pulmonary Disease
Funded at Johns Hopkins University · NIH-10998008 · Data updated 2026-11-12
This study is looking at how the high costs of treating COPD, like inhalers and hospital visits, affect patients' health and ability to stick to their treatment plans, and it aims to find ways to help ease these financial struggles.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $97,364 |
| NIH project number | 1F32HL176086-01 |
| Project ID | NIH-10998008 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with chronic obstructive pulmonary disease (COPD) who are experiencing financial difficulties related to their treatment.
✕Less likely to help
Patients with COPD who are not facing financial challenges or those who are not actively engaged in treatment may not benefit from this research.
What this research studies
This research investigates the financial burdens that individuals with chronic obstructive pulmonary disease (COPD) experience due to high treatment costs, including inhaled bronchodilators and hospital visits. It aims to explore how these financial challenges affect patients' health outcomes and medication adherence. By examining the relationship between financial toxicity and health-related quality of life, the study seeks to identify potential interventions to alleviate these burdens. The research will involve collecting data on patients' financial situations and health outcomes to better understand the impact of financial stress on their treatment adherence.
Why it matters
Potential benefit: If successful, this research could lead to improved support systems for COPD patients, helping them manage treatment costs and enhance their overall health outcomes.
How similar studies have gone: While financial toxicity has been studied in other chronic conditions, this specific focus on COPD is relatively novel and has not been extensively explored.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Mallya, Sonal — Johns Hopkins University
- Study coordinator: Mallya, Sonal
Related research
Other NIH-funded projects on the same topics.
-
Ethics-aware Multimodal AI for COPD prevention, diagnosis, and treatment
A broad AI model uses diverse health data to help predict and manage COPD in people, with an emphasis on ethics and fairness.
-
Positive airway pressure therapy for older veterans with COPD and sleep apnea overlap
A plan to see if using a CPAP/BAP therapy improves sleep, thinking, and quality of life for older veterans who have both COPD and sleep apnea.
-
Understanding how microbes and our bodies shape HIV-related COPD in LMICs
This project looks at how interactions between the human body and microbes may influence COPD in people living with HIV in low- and middle-income countries.
-
Anti-EMAP II antibody as a first-in-class treatment for COPD-related pulmonary hypertension
A first-in-class antibody treatment is being developed to help people with COPD-related pulmonary hypertension by blocking EMAP II, a molecule involved in lung injury and inflammation.
-
Non-coding RNA and COPD: how RNA structure changes with disease
A COPD research project explores how non-coding RNA structures in adults with COPD change due to genetic differences and how this affects gene activity.
-
ANT2 and mitochondrial dysfunction in COPD: how energy transport affects lung repair
This project studies how a key mitochondrial transporter (ANT2) may drive aging-like cell changes and repair problems in the lungs of people with COPD.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.